Item 5.07. Submission of Matters to a Vote of Security Holders.

On July 21, 2021, CM Life Sciences, Inc., a Delaware corporation ("CMLS" or following the "Company"), held the Special Meeting of its stockholders (the "Special Meeting"). At the Special Meeting, a total of 39,328,080 (71.06%) of CMLS's issued and outstanding shares of common stock held of record as of June 21, 2021, the record date for the Special Meeting, were present either in person or represented by proxy, which constituted a quorum. CMLS's stockholders voted on the following proposals at the Special Meeting, each of which was approved. The final vote tabulation for each proposal is set forth below.

(a) Proposal No. 1 - The Business Combination Proposal - to approve the agreement


    and plan of merger, dated as of February 9, 2021 as amended by the Amendment
    to Agreement and Plan of Merger dated May 3, 2021 (as the same may be further
    amended and/or restated from time to time, the "Merger Agreement"), by and
    among CMLS, S-IV Sub, Inc., a Delaware corporation and a wholly-owned
    subsidiary of CMLS ("Merger Sub"), and Mount Sinai Genomics, Inc. d/b/a
    Sema4, a Delaware corporation ("Sema4"), and the transactions contemplated
    thereby, including the merger of Merger Sub with and into Sema4 (the
    "Merger") with Sema4 surviving the Merger as a wholly owned subsidiary of the
    Company, and the issuance of common stock to Sema4 equity holders as merger
    consideration, (the transactions contemplated by the Merger Agreement, the
    "Business Combination" and such proposal, the "Business Combination
    Proposal"):




Votes For    Votes Against   Abstentions   Broker Non-Votes
39,300,046       4,639         23,395



(b) Proposal No. 2 - The Nasdaq Stock Issuance Proposal - to approve, assuming


    the Business Combination Proposal is approved and adopted, for the purposes
    of complying with the applicable listing rules of the Nasdaq Stock Market
    ("Nasdaq"), the issuance of more than 20% of CMLS's outstanding Class A
    common stock (the "common stock") in connection with the Business Combination
    and the subscription agreements, each dated as of February 9, 2021 (the "PIPE
    Investor Subscription Agreements"), with certain institutional investors
    (including affiliates of CMLS's sponsor and existing investors in Sema4) (the
    "PIPE Investors"), including (i) up to 35,000,000 shares of common stock to
    the PIPE Investors, which includes affiliates of CMLS's sponsor that
    subscribed for 9,500,000 shares of common stock and (ii) up to 147,922,735
    shares of common stock to holders of Sema4 capital stock pursuant to the
    terms of the Merger Agreement, (such proposal the "Nasdaq Stock Issuance
    Proposal"):




Votes For    Votes Against   Abstentions   Broker Non-Votes
39,265,951      35,563         26,566



(c) Proposal No. 3 - The Charter Approval Proposal - to approve, assuming the


     Business Combination Proposal and the Nasdaq Stock Issuance Proposal are
     approved and adopted, the proposed amended and restated certificate of
     incorporation of the Company in the form attached to CMLS's definitive proxy
     statement dated July 2, 2021 (the "Proposed Charter"), which will replace
     CMLS's current amended and restated certificate of incorporation, dated
     September 1, 2020 (the "Current Charter"), (such proposal the "Charter
     Approval Proposal"):




Votes For    Votes Against   Abstentions   Broker Non-Votes
38,632,981      669,832        25,267



(d) Proposal No.4 - Governance Proposal - to approve, on a non-binding advisory


     basis, a separate proposal, which would change the stockholder vote required
     to amend the Company's certificate of incorporation from a simple majority to
     an affirmative vote of at least two-thirds of the stockholders of the
     Company, as further described in CMLS's definitive proxy statement dated July
     2, 2021, (such proposal the "Governance Proposal"):




Votes For    Votes Against   Abstentions   Broker Non-Votes
32,316,256     6,983,639       28,185




                                       1




(e) Proposal No. 5 - The Incentive Plan Proposal - to approve, assuming the


     Business Combination Proposal, the Nasdaq Stock Issuance Proposal and the
     Charter Approval Proposal are approved and adopted, the Sema4 Holdings Corp
     2021 Equity Incentive Plan (the "Sema4 Holdings Corp Incentive Plan"),
     including the authorization of the initial share reserve under the Sema4
     Holdings Corp Incentive Plan, including with respect to the number of shares
     that may be issued pursuant to the exercise of incentive stock options
     granted (such proposal the "Incentive Plan Proposal"):




Votes For    Votes Against   Abstentions   Broker Non-Votes
34,310,920     4,942,837       74,323




(f) Proposal No. 6 - The ESPP Proposal - to approve, assuming the Business


     Combination Proposal, the Nasdaq Stock Issuance Proposal, the Charter
     Approval Proposal and the Incentive Plan Proposal are approved and adopted,
     the Sema4 Holdings Corp 2021 Employee Stock Purchase Plan (the "ESPP"),
     including the authorization of the initial share reserve under the ESPP (such
     proposal the "ESPP Proposal"):




Votes For    Votes Against   Abstentions   Broker Non-Votes
36,408,724     2,843,771       75,585



(g) Proposal No. 7 - The Director Election Proposal - to approve, assuming the


    Business Combination Proposal, the Nasdaq Stock Issuance Proposal, the
    Charter Approval Proposal, the Incentive Plan Proposal and the ESPP Proposal
    are approved and adopted (the "Condition Precedent Proposals"), the election
    of nine (9) directors to serve on the Company's board of directors, each for
    a three-year term or until such director's successor has been duly elected
    and qualified, or until such director's earlier death, resignation,
    retirement or removal; alternatively, in the event the Condition Precedent
    Proposals are not approved, to elect two directors to serve as Class I
    directors on CMLS's board of directors, each for a term of three years
    expiring at the annual meeting of stockholders to be held in 2024 or until
    such director's successor has been duly elected and qualified, or until such
    director's earlier death, resignation, retirement or removal, (such proposal
    the "Director Election Proposal"):




Votes For    Votes Against   Abstentions   Broker Non-Votes
38,456,600      47,528         823,952



(h) Proposal No. 8 - The Adjournment Proposal - to consider and vote upon a


    proposal to approve, if necessary, the adjournment of the Special Meeting to
    a later date or dates to permit further solicitation and vote of proxies in
    the event that there are insufficient votes for, or otherwise in connection
    with, the approval of any of the any of the Business Combination Proposal,
    the Nasdaq Stock Issuance Proposal, the Charter Approval Proposal, the
    Incentive Plan Proposal and the ESPP Proposal, (such proposal the
    "Adjournment Proposal"):




Votes For    Votes Against   Abstentions   Broker Non-Votes
39,273,271      21,716         33,093



(i) Proposal No. 9 - The Auditor Ratification Proposal - To consider and vote


    upon a proposal to approve the ratification of WithumSmith+ Brown, PC as
    CMLS's independent registered public accounting firm for the fiscal year
    ending December 31, 2020 (such proposal the "Auditor Ratification Proposal"):




Votes For    Votes Against   Abstentions   Broker Non-Votes
36,174,788      23,072        3,130,220




                                       2

© Edgar Online, source Glimpses